- Keurig Dr Pepper’s second-quarter net sales reached $4.16 billion, matching expectations of $4.13 billion.
- U.S. Refreshment Beverages net sales were $2.66 billion, exactly meeting projections.
- U.S. Coffee net sales exceeded expectations with $948 million compared to the estimated $920.3 million.
- International net sales amounted to $555 million.
- Volume/mix growth at constant currency achieved +5%, surpassing the estimate of +1.76%.
- The firm reaffirmed its fiscal 2025 guidance, expecting mid-single-digit growth in net sales and high-single-digit growth in adjusted diluted EPS.
- Foreign currency translation is anticipated to result in a 0.5% headwind to both top- and bottom-line growth for the year.
- CEO Tim Cofer expressed optimism about maintaining strong performance in key segments and ensuring long-term value creation, despite upcoming challenges.
- Analyst ratings are favorable, with 15 buy recommendations, 7 holds, and no sells.
Keurig Dr Pepper on Smartkarma
Analyst coverage of Keurig Dr Pepper on Smartkarma reveals insights from Baptista Research. In their report titled “Keurig Dr Pepper: Focus on Coffee Segment Strategy As A Primary Growth Accelerator!” with a bullish sentiment, strengths and concerns for potential investors were highlighted. The company’s recent earnings announcement showcased a solid financial performance, with net sales increasing by over 6% and earnings per share (EPS) growing by more than 10%, indicating resilience in the current economic environment.
Another report by Baptista Research, “Keurig Dr Pepper: International Expansion & Performance To Yield Positive Results In Long Term?“, also expressed a bullish sentiment. The analysis of KDP’s fourth quarter and full-year 2024 earnings release emphasized constant currency net sales growth of approximately 4% and earnings per share (EPS) growth of 8% for the full year. Despite challenges like inflation and supply chain constraints, KDP’s long-term performance algorithm held up. Baptista Research delves into various factors that could impact the company’s stock price in the near future and conducts an independent valuation using a Discounted Cash Flow (DCF) methodology.
A look at Keurig Dr Pepper Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Keurig Dr Pepper Inc., known for its wide range of non-alcoholic beverages, has received a decent overall outlook based on the Smartkarma Smart Scores. With a balanced score across various factors including Value, Dividend, Growth, Resilience, and Momentum, the company seems to be positioned moderately well for the long term. Keurig Dr Pepper manufactures and distributes popular drinks such as soft drinks, juices, teas, and water, serving customers in the United States, Canada, and Mexico.
While not excelling in any particular category, Keurig Dr Pepper’s consistent ratings across different aspects indicate a stable outlook with room for potential growth. Investors considering the company may find its combination of value, dividend yield, growth prospects, resilience, and momentum appealing for a diversified portfolio. Keeping an eye on how these factors evolve over time could provide valuable insights into the future performance of Keurig Dr Pepper in the beverage market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
